Patents by Inventor Clare Louise Murray

Clare Louise Murray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amido-pyridyl ether compounds and compositions and their use against parasites
    Patent number: 8946270
    Abstract: The subject matter disclosed herein is directed to amido-pyridyl ether compounds of formula I: wherein, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, Ra, a, b and d are as described herein, compositions comprising the compounds of formula I, methods for their preparation and methods for their uses against parasites.
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: February 3, 2015
    Assignee: Merial Limited
    Inventors: Charles Q. Meng, Clare Louise Murray, Itta Bluhn-Chertudi, Mustapha Soukri, Mary George Johnson
  • AMIDO-PYRIDYL ETHER COMPOUNDS AND COMPOSITIONS AND THEIR USE AGAINST PARASITES
    Publication number: 20140179746
    Abstract: The subject matter disclosed herein is directed to amido-pyridyl ether compounds of formula I: wherein, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, Ra, a, b and d are as described herein, compositions comprising the compounds of formula I, methods for their preparation and methods for their uses against parasites.
    Type: Application
    Filed: June 27, 2012
    Publication date: June 26, 2014
    Applicant: MERIAL LIMITED
    Inventors: Charles Q. Meng, Clare Louise Murray, Itta Bluhn-Chertudi, Mustapha Soukri, Mary George Johnson
  • ISOQUINOLINE COMPOUNDS
    Publication number: 20100093790
    Abstract: Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
    Type: Application
    Filed: December 16, 2009
    Publication date: April 15, 2010
    Applicant: AERIE PHARMACEUTICALS, INC.
    Inventors: Mitchell A. deLong, Marcos L. Sznaidman, Robert H. Oakley, Allen E. Eckhardt, Christine Hudson, Jeffrey D. Yingling, Michael Peel, Thomas E. Richardson, Clare Louise Murray, Byappanahally N. Narasinga Rao, Brian H. Heasley, Paresma R. Patel
  • ISOQUINOLINE COMPOUNDS
    Publication number: 20090069371
    Abstract: Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
    Type: Application
    Filed: November 20, 2008
    Publication date: March 12, 2009
    Applicant: Aerie Pharmaceuticals, Inc.
    Inventors: Mitchell A. deLong, Marcos L. Sznaidman, Robert H. Oakley, Allen E. Eckhardt, Christine Hudson, Jeffrey D. Yingling, Michael Peel, Thomas E. Richardson, Clare Louise Murray, Byappanahally N. Narasinga Rao, Brian H. Heasley, Paresma R. Patel